GURUFOCUS.COM » STOCK LIST » Asia » China » SZSE » China National Accord Medicines Corp Ltd (SZSE:000028) » Definitions » Other Operating Expense
Switch to:

China National Accord Medicines (SZSE:000028) Other Operating Expense

: ¥1,052 Mil (TTM As of Mar. 2023)
View and export this data going back to 1993. Start your Free Trial

China National Accord Medicines's Other Operating Expense for the three months ended in Mar. 2023 was ¥26 Mil. Its Other Operating Expense for the trailing twelve months (TTM) ended in Mar. 2023 was ¥1,052 Mil.

China National Accord Medicines's quarterly Other Operating Expense increased from Sep. 2022 (¥-410 Mil) to Dec. 2022 (¥966 Mil) but then declined from Dec. 2022 (¥966 Mil) to Mar. 2023 (¥26 Mil).

China National Accord Medicines's annual Other Operating Expense increased from Dec. 2020 (¥891 Mil) to Dec. 2021 (¥928 Mil) and increased from Dec. 2021 (¥928 Mil) to Dec. 2022 (¥1,034 Mil).


China National Accord Medicines Other Operating Expense Historical Data

The historical data trend for China National Accord Medicines's Other Operating Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

China National Accord Medicines Annual Data
Trend Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
Other Operating Expense
Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 721.26 762.57 891.45 928.27 1,034.17

China National Accord Medicines Quarterly Data
Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23
Other Operating Expense Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 16.90 470.67 -409.88 965.54 25.67

China National Accord Medicines Other Operating Expense Calculation

GuruFocus uses a standardized financial statement format for all companies. For non-financial companies, GuruFocus lists Selling, General, & Admin. Expense, , Research & Development, and Other Operating Expense under the "Total Operating Expense" section.

Other Operating Expense sometimes includes:
Restructuring, and merger
Acquisition related and other
Litigation settlement charge
Other (too numerous to list)

Some companies can and do choose to report each of these items separately. Yet, there are a variety of Other Operating Expense which are simply too numerous to list.

Other Operating Expense for the trailing twelve months (TTM) ended in Mar. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥1,052 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


China National Accord Medicines Other Operating Expense Related Terms

Thank you for viewing the detailed overview of China National Accord Medicines's Other Operating Expense provided by GuruFocus.com. Please click on the following links to see related term pages.


China National Accord Medicines (SZSE:000028) Business Description

China National Accord Medicines logo
Traded in Other Exchanges
Address
No. 15, Ba Gua Si 4th Road, Accord Pharmaceutical Building, Futian District, Guangdong Province, Shenzhen, CHN, 518029
China National Accord Medicines Corp Ltd develops and manufactures pharmaceuticals in China. The company engaged in the wholesale of Chinese patent drugs, traditional Chinese medicines, chemical medicine preparations, antibiotics, biochemical drugs and cerebrovascular system drugs. It operates through the following segments: The Head office segment engages in investing and managing the business; The Pharmaceutical Distribution segment engages in the distribution of medicine and pharmaceutical products to customers, including hospitals, other distributors, retail drug stores, and clinics, and Retail pharmacy segment, which is managing the operation of Guoda Pharmacy. It generates maximum revenue from the Pharmaceutical Distribution segment.

China National Accord Medicines (SZSE:000028) Headlines

No Headlines